LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and AI solutions for Latin America, announced its participation in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13-14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event will convene students, faculty, and professionals from systems engineering and healthcare disciplines to explore practical uses of AI and automation.
The company will be represented by CEO Dr. Kevin Rodan Levy and CFO Carlos Pena. Their presentation will address AI's evolving role in healthcare, systems engineering, digital infrastructure, and professional decision-making. LataMed AI will discuss how AI-supported tools can assist in medical-data evaluation, clinical workflows, and operational efficiency, while emphasizing the necessity of qualified human oversight.
"Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering," said Dr. Kevin Rodan Levy. "Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America."
The conference will also cover integration of AI into existing systems, responsible data use, privacy and security, operational risk management, and practical deployment considerations. LataMed AI will highlight its CardioAI, PulmoAI, and NeuroAI platforms, designed to assist in cardiovascular, pulmonary, and neurological health evaluations, subject to regulatory approval.
Management believes that university engagement raises awareness of emerging technologies and fosters responsible discussion, while helping the company understand perspectives from students and professionals. Participation aligns with LataMed AI's broader strategy of supporting education and responsible adoption of digital healthcare infrastructure. The company intends to continue seeking opportunities in academic and technological forums.
This event does not constitute an endorsement of LataMed AI or its technologies by Universidad Santa Maria. For more information, visit https://latamed.ai or review SEC filings at www.sec.gov.
